CD34 and neoplasm: The estimated PB-CD34+ counts necessary to reach thresholds of 2 × 106 and 5 × 106 AP-CD34+ cells/kg with a probability of 0.90 in patients with other tumor type were 50.51 (90% CI: 29.30–79.12) and 126.39 (90% CI: 77.25–198.28) × 106/L, respectively.